|
| [10] | C. C. Baaten, M. Sternkopf, T. Henning, N. Marx, J. Jankowski, H. Noels,
"Platelet Function in CKD: A Systematic Review and Meta-Analysis", J. Am. Soc. Nephrol., vol. 32, no. 7, pp. 1583–1598.
|
| [9] | Y. Döring, H. Noels, E. P. van der Vorst, C. Neideck, V. Egea, M. Drechsler, M. Mandl, L. Pawig, Y. Jansen, K. Schröder, K. Bidzhekov, R. T. Megens, W. Theelen, B. M. Klinkhammer, P. Boor, L. Schurgers, R. van Gorp, C. Ries, P. J. Kusters, A. van der Wal, T. M. Hackeng, G. Gäbel, R. P. Brandes, O. Soehnlein, E. Lutgens, D. Vestweber, D. Teupser, L. M. Holdt, D. J. Rader, D. Saleheen, C. Weber,
"Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity", Circulation, vol. 136, no. 4, pp. 388–403.
|
| [8] | C. Hemmers, C. Schulte, J. Wollenhaupt, D. W. L. Wong, E. Harlacher, S. Orth-Alampour, B. M. Klinkhammer, S. H. Schirmer, M. Böhm, N. Marx, T. Speer, P. Boor, J. Jankowski, H. Noels,
"Chemokine CCL9 is upregulated early in chronic kidney disease and counteracts kidney inflammation and fibrosis", Biomedicines, vol. 10, no. 2, pp. 420.
|
| [7] | H. Noels, M. Lehrke, R. Vanholder, J. Jankowski,
"Lipoproteins and fatty acids in chronic kidney disease: Molecular and metabolic alterations", Nat. Rev. Nephrol., vol. 17, no. 8, pp. 528–542.
|
| [6] | H. Noels, W. Theelen, M. Sternkopf, V. Jankowski, J. Moellmann, S. Kraemer, M. Lehrke, N. Marx, L. Martin, G. Marx, J. Jankowski, A. Goetzenich, C. Stoppe,
"Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery", Sci. Rep., vol. 8, no. 1, pp. 11820.
|
| [5] | C. Schmitz, H. Noels, O. E. Bounkari, E. Straussfeld, R. T. A. Megens, M. Sternkopf, S. Alampour‐Rajabi, C. Krammer, P. V. Tilstam, N. Gerdes, C. Bürger, A. Kapurniotu, R. Bucala, J. Jankowski, C. Weber, J. Bernhagen,
"Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis", The FASEB Journal, vol. 32, no. 8, pp. 4428–4443.
|
| [4] | J. Soppert, J. Frisch, J. Wirth, C. Hemmers, P. Boor, R. Kramann, S. Vondenhoff, J. Moellmann, M. Lehrke, M. Hohl, E. P. van der Vorst, C. Werner, T. Speer, C. Maack, N. Marx, J. Jankowski, L. P. Roma, H. Noels,
"A systematic review and meta-analysis of murine models of uremic cardiomyopathy", Kidney Int., vol. 101, no. 2, pp. 256–273.
|
| [3] | M. Sternkopf, M. Nagy, C. C. Baaten, M. J. Kuijpers, B. M. Tullemans, J. Wirth, W. Theelen, T. G. Mastenbroek, M. Lehrke, B. Winnerling, L. Baerts, N. Marx, I. De Meester, Y. Döring, J. M. Cosemans, A. Daiber, S. Steven, J. Jankowski, J. W. Heemskerk, H. Noels,
"Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions", Arterioscl. Throm. Vas., vol. 40, no. 3, pp. e65–e77.
|
| [2] | P. V. Tilstam, J. Soppert, C. Hemmers, E. Harlacher, Y. Döring, E. P. van der Vorst, C. Schulte, S. Alampour-Rajabi, W. Theelen, Y. Asare, M. P. de Winther, T. Lawrence, J. Bernhagen, A. Schober, A. Zernecke, J. Jankowski, C. Weber, H. Noels,
"Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice", Atherosclerosis, vol. 292, pp. 23–30.
|
| [1] | J. Wollenhaupt, J. Frisch, E. Harlacher, D. W. Wong, H. Jin, C. Schulte, S. Vondenhoff, J. Moellmann, B. M. Klinkhammer, L. Zhang, A. Baleanu-Curaj, E. A. Liehn, T. Speer, A. Kazakov, C. Werner, E. P. van der Vorst, S. Selejan, M. Hohl, M. Böhm, R. Kramann, E. A. Biessen, M. Lehrke, N. Marx, J. Jankowski, C. Maack, P. Boor, L. Prates Roma, H. Noels,
"Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease", Redox Biol., vol. 56, no. 102459, pp. 102459.
|